ウェビナー「抗菌薬研究開発促進のためのグローバルコミュニティ形成を目指して」

開催日時

　2025年11月26日 16:00 ～ 20:45

 

開催形式

　LIVE配信

 

主　　催

　日本製薬工業協会

 

概　　要

【プログラム】

Session 1 – Bridging Academia & Startups

・Development of Lysocin E: An Antibiotic with Outstanding Bactericidal Activity
– Current Status of Drug Discovery Research in Infectious Disease – Drug Discovery Startups and Challenges in Bridging the Gap to Clinical Development
　　　Dr. Hiroshi Hamamoto
　　　(Silk Strand Pharma,Yamagata University Faculty of Medicine)

・Introduction to INCATE & tailored support
　　　Mercedes González 
　　　Moreno, PhD
　　　(INCATE)

Session 2 – Promotion of Drug Development in AMR supported by INCATE
・Invitris – Cell-free protein expression
　　　Patrick Grossman
　　　PhD, MBA
　　　(CEO Invitris)

・Justus-Liebig-University Giessen – BamA Inhibitors
　　　Prof. Dr. Till F. 
　　　Schäberle
　　　(Head of Natural Product Research, Justus-Liebig-University 

 

Session 3 – Challenges in R&D Technology and Regulations for new Drug Modalities
– Showcasing Phage Therapy –Giessen)

・Next-Generation Phage Formulation Design Against MRSA: Opportunities for Collaborative Development
　　　Dr. Hidetomo Iwano
　　　(Laboratory of Veterinary Biochemistry, Department of Veterinary Medicine, Rakuno Gakuen University)

・Phage Drug Discovery: Efficacy, Challenges, and Future Potential
　　　Dr. Kotaro Kiga
　　　(Japan Institute for Health Security)

・Toward the Realization of Phage Therapy
　　　Dr. Hiroki Ando
　　　(CEO Arrowsmith Inc.)

Session 4 – Advice to Key Aspects in Phage Therapy

・Bacteriophages as Pharmaceuticals: From Research and Development to Clinical Application
　　　Ing. Milan Buňata
　　　(Business Director, FAGOFARMA)

・Tackling the Complexities of Bringing Personalized Phage Therapy to the Market
　　　Bob Blasdel, PhD
　　　(Research Director,

・EU Regulation – New Drug Modalities
　　　Dr. Miriam Fürst-Wilmes
　　　(Project manager, BfArM/DZIF)

Session 5 – Panel Discussion: From Discovery to Clinical Application
Chairs: JPMA & INCATE

・Opening Panel Discussion
　　　Moderators: Dr. Hideki Maki (JPMA|Shionogi),
　　　　　　　　  Mercedes G. Moreno, PhD (INCATE)

Topic: Bridging from academia and startups to clinical development
Subtopic: Addressing development challenges to boost phage therapy
   Panelists: Dr. Hiroshi Hamamoto (Yamagata University)
              Dr. Hidetomo Iwano (Rakuno Gakuen University)
              Dr. Kotaro Kiga (Japan Institute for Health Security)
              Dr. Hiroki Ando (Arrowsmith Inc.)
              Dr. Takeo Kohda (Silk Strand Pharma)
              Patrick Grossman, PhD, MBA (Invitris)
              Prof. Dr. Till F. Schäberle (Justus-Liebig-University Giessen)
              Ing. Milan Buňata (FAGOFARMA)
              Bob Blasdel, PhD (Inteliphage)
              Dr. Miriam Fürst-Wilmes (BfArM)
              Derry Mercer, PhD (INCATE)

 

【参加費・定員など】

・会　費：無料

・定　員： 300 名

・対応言語：プレゼンテーションは英語、日本語の同時通訳あり